Moreover, a significant DYRK2 overexpression in DYRK2-amplified tumors was also observed in HNSCC, ovary (OV), melanoma (SKCM) and sarcoma (SARC) (Table S1). This evidence concerns the gene DYRK2 and head and neck squamous cell carcinoma.